Literature DB >> 21274865

The GRACILE mutation introduced into Bcs1l causes postnatal complex III deficiency: a viable mouse model for mitochondrial hepatopathy.

Per Levéen1, Heike Kotarsky, Matthias Mörgelin, Riitta Karikoski, Eskil Elmér, Vineta Fellman.   

Abstract

UNLABELLED: Mitochondrial dysfunction is an important cause for neonatal liver disease. Disruption of genes encoding oxidative phosphorylation (OXPHOS) components usually causes embryonic lethality, and thus few disease models are available. We developed a mouse model for GRACILE syndrome, a neonatal mitochondrial disease with liver and kidney involvement, caused by a homozygous BCS1L mutation (232A>G). This gene encodes a chaperone required for incorporation of Rieske iron-sulfur protein (RISP) into complex III of respiratory chain. Homozygous mutant mice after 3 weeks of age developed striking similarities to the human disease: growth failure, hepatic glycogen depletion, steatosis, fibrosis, and cirrhosis, as well as tubulopathy, complex III deficiency, lactacidosis, and short lifespan. BCS1L was decreased in whole liver cells and isolated mitochondria of mutants at all ages. RISP incorporation into complex III was diminished in symptomatic animals; however, in young animals complex III was correctly assembled. Complex III activity in liver, heart, and kidney of symptomatic mutants was decreased to 20%, 40%, and 40% of controls, respectively, as demonstrated with electron flux kinetics through complex III. In high-resolution respirometry, CIII dysfunction resulted in decreased electron transport capacity through the respiratory chain under maximum substrate input. Complex I function, suggested to be dependent on a functional complex III, was, however, unaffected.
CONCLUSION: We present the first viable model of complex III deficiency mimicking a human mitochondrial disorder. Incorporation of RISP into complex III in young homozygotes suggests another complex III assembly factor during early ontogenesis. The development of symptoms from about 3 weeks of age provides a convenient time window for studying the pathophysiology and treatment of mitochondrial hepatopathy and OXPHOS dysfunction in general.
Copyright © 2010 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21274865     DOI: 10.1002/hep.24031

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  23 in total

Review 1.  Mitochondrial Diseases Part I: mouse models of OXPHOS deficiencies caused by defects in respiratory complex subunits or assembly factors.

Authors:  Alessandra Torraco; Susana Peralta; Luisa Iommarini; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-02-04       Impact factor: 4.160

Review 2.  Biogenesis of the cytochrome bc(1) complex and role of assembly factors.

Authors:  Pamela M Smith; Jennifer L Fox; Dennis R Winge
Journal:  Biochim Biophys Acta       Date:  2011-11-22

3.  Renal manifestations of primary mitochondrial disorders.

Authors:  Josef Finsterer; Fulvio Alexandre Scorza
Journal:  Biomed Rep       Date:  2017-04-12

4.  Respiratory chain enzyme deficiency induces mitochondrial location of actin-binding gelsolin to modulate the oligomerization of VDAC complexes and cell survival.

Authors:  Alberto García-Bartolomé; Ana Peñas; Lorena Marín-Buera; Teresa Lobo-Jarne; Rafael Pérez-Pérez; María Morán; Joaquín Arenas; Miguel A Martín; Cristina Ugalde
Journal:  Hum Mol Genet       Date:  2017-07-01       Impact factor: 6.150

5.  CLPP deficiency protects against metabolic syndrome but hinders adaptive thermogenesis.

Authors:  Christina Becker; Alexandra Kukat; Karolina Szczepanowska; Steffen Hermans; Katharina Senft; Christoph Paul Brandscheid; Priyanka Maiti; Aleksandra Trifunovic
Journal:  EMBO Rep       Date:  2018-03-27       Impact factor: 8.807

6.  Differential proteomic profiling unveils new molecular mechanisms associated with mitochondrial complex III deficiency.

Authors:  Lorena Marín-Buera; Alberto García-Bartolomé; María Morán; Elia López-Bernardo; Susana Cadenas; Beatriz Hidalgo; Ricardo Sánchez; Sara Seneca; Joaquín Arenas; Miguel A Martín; Cristina Ugalde
Journal:  J Proteomics       Date:  2014-09-18       Impact factor: 4.044

7.  Metabolite profiles reveal energy failure and impaired beta-oxidation in liver of mice with complex III deficiency due to a BCS1L mutation.

Authors:  Heike Kotarsky; Matthias Keller; Mina Davoudi; Per Levéen; Riitta Karikoski; David P Enot; Vineta Fellman
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

Review 8.  Development of pharmacological strategies for mitochondrial disorders.

Authors:  M Kanabus; S J Heales; S Rahman
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 9.  Nuclear gene mutations as the cause of mitochondrial complex III deficiency.

Authors:  Erika Fernández-Vizarra; Massimo Zeviani
Journal:  Front Genet       Date:  2015-04-09       Impact factor: 4.599

10.  Complex I function and supercomplex formation are preserved in liver mitochondria despite progressive complex III deficiency.

Authors:  Mina Davoudi; Heike Kotarsky; Eva Hansson; Vineta Fellman
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.